Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
07/15/2008 | US7399771 Piperidine derivatives as CCR5 inhibitors |
07/15/2008 | US7399320 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride |
07/10/2008 | WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
07/10/2008 | WO2008082041A1 Process for preparing lercanidipine hydrochloride |
07/10/2008 | WO2008081726A1 Process for production of amide or lactam |
07/10/2008 | WO2008081477A1 3-aryloxy 3-substituted propanamines |
07/10/2008 | WO2008080934A1 Stable s-nitrosothiols, method of synthesis and use |
07/10/2008 | WO2008080601A2 Process for the preparation of loperamide |
07/10/2008 | WO2007115821A3 Organic compounds |
07/10/2008 | WO2007062335A8 New pleuromutilin derivative and its use |
07/10/2008 | US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators |
07/10/2008 | US20080167470 Process of enantiomeric resolution of D,L-(+_)-threo-methylphenidate |
07/10/2008 | US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate |
07/10/2008 | US20080167352 3-(4-Chloro-phenyl)-adamantane-1-carboxylic acidisopropylamide; antiproliferative, antiinflammatory agent, angiogenesis inhibitor; sphingolipid-derived signaling pathway; coupling acid or acylhalide of phenyl-adamantane derivatives with aminoalkyl-pyridine |
07/10/2008 | US20080167347 Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives |
07/10/2008 | US20080167332 Novel Compounds 243 |
07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
07/10/2008 | US20080166332 Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease Inhibitors |
07/10/2008 | CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
07/09/2008 | EP1940790A2 Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
07/09/2008 | EP1940783A1 Process for preparing n, n-substituted carbamoyl halides |
07/09/2008 | EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
07/09/2008 | EP1720825B1 Anthranilic acid derivatives, methods for their preparation and use as dhodh inhibitors |
07/09/2008 | EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
07/09/2008 | CN101215285A Polyhydroxy substituted octahydroindolizidine and synthesis method thereof |
07/09/2008 | CN101215258A Dihydropyridines calcium antagonist compounds, preparation method and medical use thereof |
07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
07/09/2008 | CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
07/09/2008 | CN100400511C Cathepsin S inhibitors |
07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
07/08/2008 | US7396930 making spiro(benzo(c)thiophene-1 (3H),4'-piperidine) derivatives; involves reacting a mercapto compound with a 2-halophenylalkyl halide, reacting with an alkyllithium, then N-ethoxycarbonyl-4-piperidone, dehydration and cyclization; industrial scale; novel intermediates to neurokinin receptor antagonist |
07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
07/03/2008 | WO2008079284A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds |
07/03/2008 | WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
07/03/2008 | WO2008077811A1 Spiro-piperidine derivatives |
07/03/2008 | WO2008077810A2 Spiro-piperidine derivatives |
07/03/2008 | WO2008057721A3 Water tolerant emulsion stabilizers |
07/03/2008 | WO2008041184A3 Muscarinic receptor antagonists |
07/03/2008 | WO2007114902A3 Alkylthiobenzylpiperidine compounds |
07/03/2008 | US20080161577 Muscarinic receptor antagonists; longer duration of action; side effect reduction; high potency; chronic obstructive pulmonary disease; asthma; inhalation; 2-[(S)-1-(8-Methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide |
07/03/2008 | US20080161576 Mixing a quaternary ammonium salt with an organic solvent in a vessel under an inert atmosphere; used as phase transfer catalysts; salts are substantially free of degradation products and are in a form suitable for use with commercial scale reactions |
07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
07/03/2008 | US20080161354 Stable s-nitrosothiols, method of synthesis and use |
07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
07/03/2008 | DE102006061533A1 Verfahren zur Herstellung von 2-Aminomethylpiperidin A process for the preparation of 2-aminomethylpiperidine |
07/03/2008 | CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure |
07/03/2008 | CA2674518A1 Spiro-piperidine derivatives |
07/03/2008 | CA2673307A1 Spiro-piperidine derivatives |
07/03/2008 | CA2673233A1 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds |
07/03/2008 | CA2664118A1 Protease inhibitors |
07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
07/02/2008 | EP1939179A1 Stable S-nitrosothiols, method of synthesis and use |
07/02/2008 | EP1939178A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine or hydrochloride thereof |
07/02/2008 | EP1939177A2 Method for manufacturing 2-aminomethylpiperidin |
07/02/2008 | EP1937726A1 Inhibition of polymerisation |
07/02/2008 | EP1937252A2 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
07/02/2008 | EP1830841B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
07/02/2008 | EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators |
07/02/2008 | EP1633702B1 Protease inhibitors |
07/02/2008 | EP1496838A4 Substituted amides |
07/02/2008 | EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase |
07/02/2008 | CN101213185A Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
07/02/2008 | CN101212974A 4-fluoro-piperidine T-type calcium channel antagonists |
07/02/2008 | CN101209991A Method for preparing S-(-)-amlodipine |
07/02/2008 | CN101209990A Resolution method for 3-piperidine formic acid ester |
07/02/2008 | CN101209989A Method for manufacturing 2-aminomethylpiperidin |
07/02/2008 | CN100398539C Synthesis of heteroaryl acetamides |
07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
07/02/2008 | CN100398534C New method of synthesizing thalidomide and its derivative |
07/02/2008 | CN100398533C Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
07/01/2008 | US7393873 Arylsulfonamide derivatives |
07/01/2008 | US7393861 Derivatives of 4-aminopiperidine and their use as a medicament |
07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
06/26/2008 | WO2008075077A1 Piperidine derivatives for the treatment of obesity |
06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
06/26/2008 | WO2008075064A1 Piperidine derivatives for the treatment of obesity |
06/26/2008 | WO2008075040A2 Radioactive pet agents for imaging ccr5 in vivo |
06/26/2008 | WO2008075006A1 Piperldinum compounds for treatment of obstructive pulmonary diseases ( copd) |
06/26/2008 | WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
06/26/2008 | WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives |
06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
06/26/2008 | US20080153878 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one ; for therapy of Alzheimer's disease, myasthenia gravis, Huntingtons disease or glaucoma |
06/26/2008 | US20080153851 Cycloalkyl Piperidine Tachykinin Receptor Antagonists |
06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
06/26/2008 | US20080153843 Bradykinin 1 receptor (B1R) antagonists for treating various inflammatory diseases, pain, obesity; compounds bind to both rat and human receptors for pharmacological testing; ether and amide-functional N-heterocycle sulfonamides |
06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
06/26/2008 | DE20122843U1 Fentanyl Zusammensetzung zur nasalen Anwendung Fentanyl composition for nasal administration |
06/26/2008 | DE102007059495A1 Verfahren zur Addition von Hydrazin an Acrylmakromonomere und Produkte daraus Process for the addition of hydrazine to Acrylmakromonomere and products thereof |
06/26/2008 | CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
06/25/2008 | EP1935884A2 New crystalline forms of donepezil base |
06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
06/25/2008 | EP1934264A2 Amido-organoborate initiator systems |